Thus, in lung cancer and glioma cells, BMAL1 knockdown induced cancer cell invasion in parallel with activation of the PI3K/Akt/MMP2 pathway [112], whereas, in drug-resistant metastatic colorectal cancer, BMAL1 promotes expression of genes involved in angiogenesis and tumor progression. The gene discussed is BMAL1; the disease is lung carcinoma.